Reversible Lansoprazole-Induced Interstitial Lung Disease Showing Improvement after Drug Cessation

Lansoprazole is an acid proton-pump inhibiting drug that is used for the treatment of duodenal or gastric ulcers, H. pylori infection, gastroesophageal reflux disease or Zollinger-Ellison syndrome. Although lansoprazole is well known for its gastrointestinal and dermatologic adverse effects, mild pu...

Descripción completa

Detalles Bibliográficos
Autores principales: Hwang, Kyu-won, Woo, Ok Hee, Yong, Hwan Seok, Shin, Bong Kyung, Shim, Jae Jeong, Kang, Eun-Young
Formato: Texto
Lenguaje:English
Publicado: The Korean Radiological Society 2008
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2627222/
https://www.ncbi.nlm.nih.gov/pubmed/18385565
http://dx.doi.org/10.3348/kjr.2008.9.2.175
Descripción
Sumario:Lansoprazole is an acid proton-pump inhibiting drug that is used for the treatment of duodenal or gastric ulcers, H. pylori infection, gastroesophageal reflux disease or Zollinger-Ellison syndrome. Although lansoprazole is well known for its gastrointestinal and dermatologic adverse effects, mild pulmonary symptoms are also known to develop from taking this drug. There have been no reports about lansoprazole-induced interstitial lung disease. We report here a case of lansoprazole-induced interstitial lung disease that developed in a 66-year-old man.

Ejemplares similares